2025-02-11 19:01 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.085 | News Release200 | Ventripoint holders exercise options for 153,200 shares |
2025-02-10 18:48 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.09 | News Release200 | Ventripoint closes $87,000 third tranche of placement |
2025-01-30 17:12 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.10 | News Release200 | Ventripoint appoints Pringle to business advisory board |
2025-01-23 19:34 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.10 | Shareholders Letter212 | Ventripoint sets out 2025 objectives |
2025-01-21 17:47 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.105 | News Release200 | Ventripoint submits VMS+ 4.0 to FDA for clearance |
2025-01-20 17:26 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.10 | News Release200 | Ventripoint closes $169,000 second tranche of placement |
2025-01-10 16:19 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.10 | News Release200 | Ventripoint to issue 83,864 shares for interest payment |
2024-12-20 19:00 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.10 | News Release200 | Ventripoint plans to extend debenture financing |
2024-12-18 17:33 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.10 | News Release200 | Ventripoint, Ascend sign term sheet for licensing deal |
2024-12-17 17:35 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.09 | News Release200 | Ventripoint closes first tranche of debenture financing |
2024-12-13 17:25 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.10 | Shares for Debt330 | Ventripoint Diagnostics 112,210 shares for debt |
2024-12-09 20:06 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.105 | News Release200 | Ventripoint to issue shares for debenture interest |
2024-12-04 08:47 | CC:VPT | VentriPoint Diagnostics Ltd. | 0.09 | News Release200 | Ventripoint Provides Corporate Update and Announces Shareholder Teleconference |
2024-11-29 15:55 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.12 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-11-29 15:55 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.12 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-11-27 20:14 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.125 | Shares for Debt330 | Ventripoint Diagnostics 128,900 shares for debt |
2024-11-22 17:09 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.135 | News Release200 | Ventripoint closes $19,335 debt settlement |
2024-11-19 17:42 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.14 | News Release200 | Ventripoint creates sales program for U.S. expansion |
2024-11-15 18:53 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.14 | Private Placement250 | Ventripoint 2,845,771-share private placement |
2024-11-14 16:14 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.14 | News Release200 | Ventripoint closes final tranche of private placement |
2024-11-07 19:17 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.145 | Private Placement - Debenture255 | Ventripoint $300,000 debenture private placement |
2024-11-06 14:30 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.15 | News Release200 | Ventripoint Diagnostics arranges $1-million financing |
2024-10-24 15:46 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.15 | News Release200 | Ventripoint receives CE Mark certification for VMS+4.0 |
2024-10-18 15:27 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.155 | News Release200 | Ventripoint closes $458,587 first financing tranche |
2024-10-15 16:14 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.155 | News Release200 | Ventripoint extends placements, increases LIFE offering |
2024-10-11 10:20 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.165 | News Release200 | Ventripoint submits VMS+4.0 for EU MDR approval |
2024-10-08 15:52 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.18 | News Release200 | Ventripoint Diagnostics completes three quality audits |
2024-09-30 08:16 | CC:VPT | VentriPoint Diagnostics Ltd. | 0.17 | News Release200 | Ventripoint Selected as Trusted Solution for Cardiac Imaging; Featured at the Take Heart Conference |
2024-09-20 17:30 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.17 | News Release200 | Ventripoint closes $300K tranche of debenture offering |
2024-09-17 14:45 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.17 | News Release200 | Ventripoint Diagnostics amends $500,000 financing |
2024-09-09 17:53 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.17 | News Release200 | Ventripoint grants options to buy 2.91M shares |
2024-09-09 17:15 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.17 | News Release200 | Ventripoint hires Empire Relations for IR services |
2024-09-09 16:46 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.17 | News Release200 | Ventripoint to launch reference site program |
2024-08-29 17:45 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.19 | News Release200 | Ventripoint arranges $500,000 private placement |
2024-08-29 03:48 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.19 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-08-29 03:36 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.19 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-08-28 14:23 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.19 | News Release200 | Ventripoint Diagnostics arranges finacnings |
2024-08-21 13:01 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.185 | News Release200 | Ventripoint Diagnostics receives medical device licence |
2024-08-14 18:47 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.195 | Private Placement - Debenture255 | Ventripoint $184,000 debenture private placement |
2024-08-12 16:07 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.20 | News Release200 | Ventripoint applies for VMS+4.0 Health Canada licence |
2024-07-02 15:53 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.205 | News Release200 | Ventripoint closes $184,000 second tranche of placement |
2024-06-27 16:35 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.205 | News Release200 | Ventripoint to seek TSX-V approval to extend placement |
2024-06-24 10:30 | CC:VPT | VentriPoint Diagnostics Ltd. | 0.215 | News Release200 | Ventripoint to Present its AI-enhanced Cardiac Ultrasound Technology to B.C. and Canadian Health Care Leaders at The Data Effect |
2024-06-13 12:40 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.21 | News Release200 | Ventripoint appoints Dobson as marketing director |
2024-06-11 11:29 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.22 | News Release200 | Ventripoint Diagnostics to hold teleconference June 14 |
2024-05-31 01:25 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.22 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-05-31 01:18 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.22 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-05-29 20:26 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.22 | Private Placement - Debenture255 | Ventripoint $941,000 debenture private placement |
2024-05-14 16:38 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.23 | News Release200 | Ventripoint to seek TSX-V OK to extend placement |
2024-05-13 13:11 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.245 | News Release200 | Ventripoint closes $941,000 1st financing tranche |
2024-05-06 13:03 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.25 | News Release200 | Ventripoint Diagnostics submits VMS+4.0 to FDA |
2024-05-01 13:57 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.21 | News Release200 | Ventripoint sells second VMS+ unit to Duke University |
2024-04-30 01:50 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.22 | SEDAR MD & A815 | SEDAR MD & A |
2024-04-30 01:22 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.22 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2024-04-11 13:49 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.22 | News Release200 | Ventripoint arranges $3-million debenture financing |
2024-03-28 12:19 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.225 | News Release200 | Ventripoint Diagnostics outlines quarterly activities |
2024-03-04 14:38 | CC:VPT | Ventripoint Diagnostics Ltd (2) | 0.28 | News Release200 | Ventripoint Diagnostics releases VMS+3.2 |